Urology Reconstruction Meshes Market
Surgical mesh refers to a thin substance that is utilized to strengthen tissue. Surgical meshes are made from synthetic polymers and biopolymers. Acellular collagen, polycaprolactone, and polypropylene are amongst the materials utilized to make surgical meshes. In women, surgical meshes are utilized to treat pelvic organ prolapse and stress urine incontinence while males use them to repair hernias. The techniques for treating pelvic organ prolapse include transabdominal and transvaginal mesh implantation. Mesh slings are also used to address incontinence due to stress. Growing prevalence of urine incontinence to support expansion of the global urology reconstruction meshes market in the years to come.
Urinary incontinence is caused by a variety of factors including constipation, pregnancy, blockage, and infection. The prevalence of urine incontinence is greater amongst the elderly people than others, according to the World Health Organization (WHO). In addition to that, a spike in the proportion of hernia repair surgeries is expected to drive the development of the global urology reconstruction meshes market. According to an article published in Visceral Medicine, approximately 20 million people worldwide have hernia repair procedures each year. Complications linked with surgical meshes include bleeding, infection, and urinary difficulties, which is likely to limit growth of the market to some extent.
Urology Reconstruction Meshes Market – Overview
The vendor landscape in the urology reconstruction meshes market is highly fragmented due to the presence of large number of established players. New product launch, M&A, and strategic collaborations are key growth strategies of vendors in the urology reconstruction meshes market. Dolphin Mesh for laparoscopic stress-free hernia repair from Futura Surgicare Pvt. Ltd, India is a example of novel product release in the urology reconstruction meshes market. KOLLSUT offers surgical hernia mesh and surgical sutures. The two companies have a wide distribution network across Italy, Azerbaijan, and Iraq via MultiMedical Lebanon SARL, AIESI Hospital Service S.A.S, and SET MEDICAL LLC.
Players in the urological reconstruction meshes are developing new devices for expanded applications. For example, Boston Scientific Corporation is engaged in the development, manufacture, and marketing of medical devices for use in interventional medical specialties. Key players in the urology reconstruction meshes market are also striving to expand distribution to individual healthcare professionals, alternate health sites, extended healthcare facilities, and not limit distribution to hospitals. For example, B. Braun Melsungen AG - a leading manufacturer of medical technology and pharmaceutical products is a leading provider of medical devices, and operates via four subsidiaries: Hospital Care, Aesculap, Avitum, and Out-patient Market.
Urology Reconstruction Meshes Market - Introduction
Surgical mesh is a thin material used for tissue reinforcement. Biopolymers and synthetic polymers are used to manufacture surgical meshes. Materials used to manufacture surgical meshes include polypropylene, polycaprolactone, and acellular collagen. Surgical meshes are used to treat stress urinary incontinence and pelvic organ prolapse in woman, and in men it is used for hernia repair. Transvaginal insertion and transabdominal insertion of mesh are the procedures utilized to treat pelvic organ prolapse. Moreover, mesh slings are used to treat stress urinary incontinence.
Urology Reconstruction Meshes Market – Competitive Landscape
The global urology reconstruction meshes market is highly fragmented due to the presence of large number of players. A large number of manufacturers hold prominent market shares in their respective regions. Futura Surgicare Pvt. Ltd., a manufacturer in India, offers Dolphin Mesh for laparoscopic tension-free hernia repair. KOLLSUT offers surgical sutures and hernia mesh. The company distributes products across Italy, Iraq, and Azerbaijan through AIESI Hospital Service S.A.S., MultiMedical Lebanon SARL, and SET MEDICAL LLC, respectively.
Acquisition, product launch among key players is likely augment the global urology reconstruction meshes market.
Identify the key factors that will drive your company’s growth, Request a brochure of this report here
Boston Scientific Corporation (AMS)
Founded in 1960, headquarter in Marlborough, U.S. Boston Scientific Corporation is engaged in the development, manufacture, and marketing of medical devices that are utilized in interventional medical specialties. The company operates through three reportable business segments: cardiovascular, rhythm management, and MedSurg. The MedSurg segment offers products for endoscopy, urology & pelvic health, and neuromodulator.
Becton Dickinson & Company (C. R. Bard),
Incorporated in 1897, headquarter in New Jersey, U.S. C. R. Bard is a leading company that designs, develops, manufactures, packages, distributes, and sells surgical, medical, patient care devices, and diagnostic. It provides a wide range of products to hospitals, individual health care professionals, extended care health facilities, and alternate site facilities on a global basis. The company offers the product for urology, vascular, oncology, and surgical specialty under the BD Interventional segment. In 2018, company launched BD Interventional segment with urological products portfolio. In April 2017, Becton, Dickinson acquired C. R. Bard. This acquisition enabled the company to achieve leadership in medication management and infection prevention, thereby enhancing growth opportunities for the combined company in the non-U.S. markets.
- Braun Melsungen AG
Established in 1839, headquarter in Tuttlingen, Germany. B. Braun Melsungen AG is a leading manufacturer of medical technology and pharmaceutical products as well as provider of medical services. The company operates through major four divisions: Aesculap, Avitum, Hospital Care, and Out-patient Market.
Founded in 1949. Medtronic headquarter in Dublin, Ireland. Medtronic is a leading medical devices company that develops, manufactures, and markets products for alleviating pain and restoring normal health of patients. The company operates through four business segments: cardiac & vascular group, minimally invasive therapies group, restorative therapies group, and diabetes group. In March 2014, Medtronic plc launched Symbotex composite mesh in the U.S. for the treatment of open ventral hernia repair. It is dual sided mesh which is made from macrospores monofilament mesh. This product launched enabled to broaden the choice of surgeon for the treatment of hernia repair.
Coloplast Corp founded in 1978. It is one of the leading players engaged in developing and manufacturing the products for wound care, skin care and urology interventional products.
Expanding operations in future? To get the perfect launch ask for a custom report here
Urology Reconstruction Meshes Market – Dynamics
Driver - Rising prevalence of Urinary Incontinence & Hernia Repair
Urinary tract infection, obstruction, pregnancy, and constipation etc. leading to urinary incontinence. According to the World Health Organization (WHO), prevalence of urinary incontinence is higher among older men and women. Furthermore, increase in number of hernia repair procedures is likely propel the growth of the market. An article published in Visceral Medicine stated that an estimated 20 million patients undergo hernia repair procedure across the worldwide each year.
Restrain – Complication Associated with Mesh & Product Recall
Urinary problems, infection and bleeding are the complications associated with the surgical meshes. For instance, In April 2019, the Food and Drug Administration ordered to stop the sale and distribution of surgical meshes for pelvic organ prolapse in the U.S. due to safety concerns among women.
Urology Reconstruction Meshes Market – Segmentation
The urology reconstruction meshes market can be bifurcated on the basis of: material, application, and region.
In terms of material, the urology reconstruction meshes market can be divided into:
- Absorbable synthetic polymer
- Non-absorbable synthetic polymer
Based on application, the urology reconstruction meshes market can be fragmented into:
- Pelvic organ prolapse
- Hernia repair
- Stress urinary incontinence
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.